One of the most aggressive and disastrous forms of cancer is neuroendocrine carcinoma of colon. The worst part of this disease is that it is usually detected at the advanced stages where is it very difficult to curb it and treat it.

As the symptoms of neuroendocrine colon cancer become visible only at very advanced stages, the survival rate of the patient diminishes. The polyps or tumors of the colon are malignant and are usually detected with distant metastases. In several surveys, the reports have revealed that most of the cases of neuroendocrine cancer result in to death.

Although the possibilities of neuroendocrine carcinoma in colon are very rare, but if unfortunately one is affected by this disease, the health of the patient becomes worse than those who are suffering form adenocarcinoma.

Researches have showcased that the results of this cancer do not differ with age, sex or tumor location. However, neuroendocrine colon carcinoma does depend on the stage of the tumor. The usual trends have revealed that people in stage 1 and 2 of cancer do not suffer from neuroendocrine colon cancer. On the other hand, in several cases, if the tumor is in stage 3 or 4, it is a laborious and tough job to treat the neuroendocrine colon carcinoma.

The medical science has very few methods to treat this kind of cancer. One of the most popular methods that the doctors often use is immunohistochemical staining methods. This method helps the doctors to detect the severity of the neuroendocrine colon cancer and helps to determine the suitable medication and treatment for it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. It involves the staining of the tumor with a monoclonal antibody A-80. This process of staining helps to identify the quantum of neuroendocrine differentiation and the extent of damage caused to the health.

Neuroendocrine colon carcinoma is hard to treat. In a case study wherein several patients suffered from this disease were examined, it was observed that the average survival rate for this disease was approximately seven months. While in a predominant stage, the rates were as less as five months. Most of these cases were initially detected as carcinoids but later they developed in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer has poor prognosis. Also surgery is not a cent percent successful treatment. So, even surgery does not provide a satisfactory cure. Therefore it becomes necessary to detect this disease on time and provide proper medication for it.